Editorial: Artificial intelligence in predicting, determining and controlling cell phenotype or tissue function in inflammatory diseases

• Melanie L. Hart,
• Ryuji Kato,
• Ryuji Kato,
• Bernd Rolauffs

Affiliations

Melanie L. Hart

G.E.R.N. Research Center for Tissue Replacement, Regeneration & Neogenesis, Department of Orthopedics and Trauma Surgery, Faculty of Medicine, Medical Center—Albert-Ludwigs-University of Freiburg, Freiburg im Breisgau, Germany

Ryuji Kato

Division of Bioscience, Department of Basic Medicinal Sciences, Graduate School of Pharmaceutical Sciences, Nagoya University, Nagoya, Japan

Ryuji Kato

Division of Micro-Nano Mechatronics, Institute of Nano-Life-Systems, Institute for Innovation for Future Society, Nagoya University, Nagoya, Japan

Bernd Rolauffs

G.E.R.N. Research Center for Tissue Replacement, Regeneration & Neogenesis, Department of Orthopedics and Trauma Surgery, Faculty of Medicine, Medical Center—Albert-Ludwigs-University of Freiburg, Freiburg im Breisgau, Germany